PA
VIVE

Perceptive Advisors’s VIVEVE MED INC VIVE Stock Holding History

Perceptive Advisors’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-335
Closed -$1.23M – 152
2018
Q1 		$1.23M Buy
+335
New +$1.46M 0.03% 104
2017
Q4 		– Sell
-487
Closed -$2.55M – 161
2017
Q3 		$2.55M Sell
487
-403
-45% -$2.48M 0.1% 87
2017
Q2 		$6.39M Sell
890
-49
-5% -$365K 0.32% 59
2017
Q1 		$5.94M Buy
+939
New +$4.57M 0.34% 55

Other funds holding VIVE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Perceptive Advisors's VIVE Position: Q2 2018 in Review

Perceptive Advisors sold out of VIVEVE MED INC (VIVE) in Q2 2018, closing a stake of 335 shares — an estimated $1.23M sold.

Perceptive Advisors first reported a position in VIVE in Q1 2017 and held it in 4 quarters. The position peaked at $6.39M in Q2 2017. 46 funds tracked by Wall St. Rank hold VIVE as of Q2 2018.

  • Perceptive Advisors reported no remaining VIVEVE MED INC position as of Q2 2018 after selling out during the quarter.
  • Perceptive Advisors sold 335 VIVEVE MED INC shares in Q2 2018, an estimated $1.23M.
  • Perceptive Advisors first reported a position in VIVEVE MED INC in Q1 2017 and held it in 4 quarters.
  • Perceptive Advisors's VIVEVE MED INC position peaked at $6.39M in Q2 2017.
  • 46 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q2 2018.

Based on Perceptive Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.